“…Out of the active compounds of CQCQD, baicalein, baicalin, chrysin, honokiol, magnolol, and salidroside, all demonstrated marked potential for high affinity binding to AKT1, with chrysin being the most potent. While previous studies have reported that some of these compounds can improve AP in the in vivo or in vitro models ( Li et al, 2018 ; Pu et al, 2019 ), the evidence that CQCQD components modulate oxidative stress or the PI3K/Akt pathway is marginal. In different diseases, honokiol was used as an inhibitor of Akt activation ( Zhai et al, 2005 ), and chrysin was postulated to modulate the PI3K/Akt pathway ( Zhou et al, 2021 ).…”